PH4-21422-82801
2 vaccinations
4 coded responses
21 check-ins
4 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 931 / CA
- Registered
- 2021-03-13
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-13
Registered in v-safe
-
2021-03-13
Dose 1 — Pfizer-BioNTech
-
2021-03-13
Health check-in — day 0, dose 1Feeling: Good · Site: Pain, Redness, Swelling · Fatigue or tirednessAdult check-in
-
2021-03-14
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain, Swelling · Fatigue or tirednessAdult check-in
- 2021-03-17
-
2021-03-19
Survey response — days 1–6 daily, dose 1MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Swollen and painful lymph nodesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-22
- 2021-03-27
-
2021-04-02
Dose 2 — Pfizer-BioNTech
-
2021-04-03
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
- 2021-04-04
- 2021-04-05
- 2021-04-06
-
2021-04-07
Health check-in — days 1–6 daily, dose 2Feeling: Good · Fatigue or tiredness, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activitiesAdult check-in
-
2021-04-08
Survey response — days 1–6 daily, dose 2MedDRA: Depression — Feeling: Fair · Fatigue or tiredness · Be unable to work or attend schoolFree text: Feeling unusually depressed since I got the 2nd shot.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-11
- 2021-04-16
- 2021-04-23
- 2021-04-30
- 2021-05-07
- 2021-05-14
- 2021-07-02
-
2021-10-01
Survey response — 6 months, dose 2MedDRA: COVID-19, Constipation, Heavy menstrual bleeding, Parosmia, Vaginal infection — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Heavy periodsCovid infectionConstipationVaginal InfectionsSense of smell impairedMedDRA releases: 2024-11 · check-in free text available
-
2021-10-01
Report sent to call center — 6 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2021-11-11
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
-
2022-04-02
Survey response — 12 months, dose 2MedDRA: Heavy menstrual bleeding, Menstrual disorder, Noninfective oophoritis, Pelvic pain — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Ovary inflammation, pelvic pain, menstrual irregularities, heavy bleedingMedDRA releases: 2024-11 · check-in free text available
-
2022-04-02
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-04-04
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-13 | Pfizer-BioNTech | |
| 2 | 2021-04-02 | Pfizer-BioNTech |
Call center
2 call center cases
1 successful · 1 unsuccessful
Free text
Release 5 — days 1–6 daily, dose 1
Systemic reaction (other): Swollen and painful lymph nodes
Release 7 — days 1–6 daily, dose 2
Systemic reaction (other): Feeling unusually depressed since I got the 2nd shot.
Release 9 — 6 months, dose 2
Symptoms: Heavy periodsCovid infectionConstipationVaginal InfectionsSense of smell impaired
Release 11 — 12 months, dose 2
Symptoms: Ovary inflammation, pelvic pain, menstrual irregularities, heavy bleeding
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Constipation | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Heavy menstrual bleeding | · | · | ✓ |
| SD | Menstrual disorder | · | · | ✓ |
| SD | Noninfective oophoritis | · | · | ✓ |
| SD | Parosmia | · | · | ✓ |
| SD | Pelvic pain | · | · | ✓ |
| SD | Vaginal infection | · | · | ✓ |
| SRO | Depression | ✓ | ✓ | ✓ |
| SRO | Lymph node pain | ✓ | ✓ | ✓ |
| SRO | Lymphadenopathy | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release